Oculis Holding AG Warrants Share Price
NASDAQ: OCSAW$2.78
+$2.78 (--%) Last updated on 15 Oct, 2026 | 21:12 ISTOculis Holding AG Warrants Stock Performance
Oculis Holding AG Warrants Share Price Chart
$2.28$2.32
L
H
Oculis Holding AG Warrants Annual Profit & Loss
All figures in USD
About Oculis Holding AG Warrants
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Oculis Holding AG Warrants Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.28 | $2.78 | -5.12% |
Sep 2026 | $3.16 | $2.93 | -37.66% |
Aug 2026 | $4.03 | $4.70 | +20.82% |
Jul 2026 | $4.00 | $3.89 | -2.75% |
Jun 2026 | $4.06 | $4.00 | -63.80% |
May 2026 | $17.44 | $11.05 | -26.63% |
Apr 2026 | $15.06 | $15.06 | -4.38% |
Mar 2026 | $15.75 | $15.75 | -10.00% |
Feb 2026 | $17.49 | $17.50 | +6.45% |
Jan 2026 | $10.30 | $16.44 | +104.22% |
Nov 2025 | $8.05 | $8.05 | -12.50% |
Oct 2025 | $7.25 | $9.20 | +50.82% |